Trhde - thyrotropin-releasing hormone degrading enzyme Gene
Also Known as PAP-II
Species: Rattus norvegicus
Gene Type: protein coding
Gene ID: 366894
Summary
Predicted to enable metalloaminopeptidase activity; peptide binding activity; and zinc ion binding activity. Predicted to be involved in several processes, including peptide catabolic process; proteolysis; and regulation of blood pressure. Predicted to be integral component of membrane. Predicted to be active in cytoplasm and plasma membrane. Orthologous to human TRHDE (thyrotropin releasing hormone degrading enzyme). [provided by Alliance of Genome Resources, Apr 2022]
Trhde Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_001108991.2 | NP_001102461.1 | thyrotropin-releasing hormone-degrading ectoenzyme |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
thyrotropin-releasing hormone-degrading ectoenzyme |
|
|
Related Agents
- Pre-clinical Phase
Pre-clinical Phase
Bioactive Molecules
(5)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P10485 | Glp-Asn-Pro-AMC | 99.26% | Unkown | |
| HY-P4584 | TRH-βNA | / | Unkown | |
| HY-RS15012 | TRHDE Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS22877 | Trhde Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS29391 | Trhde Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service